The diagnostic accuracy (area under the receiver operating characteristic curve [AUC]) of CSF Ng in differentiating patients with AD from CN was comparable to that of the core CSF biomarkers (Figure 2A). This evidence concerns the gene NRGN and Alzheimer disease.